Eric J. Schoen
Chief Financial OfficerMr. Eric J. Schoen has been Chief Financial Officer of Filana Therapeutics, Inc. (formerly known as Cassava Sciences, Inc.) (formerly known as Pain Therapeutics, Inc.) since October 31, 2018. Mr. Schoen served as the Chief Accounting Officer at Vermillion, Inc. (know as Aspira Women’s Health Inc.) since October 6, 2011 until December 18, 2017 and served as its Senior Vice President of Finance since July 12, 2016 until December 18, 2017 and served as its Vice President of Finance since May 31, 2013. Mr. Schoen joined Vermillion in July 2010 as Corporate Controller. Prior to Vermillion, he served as Revenue Controller for Borland Software from 2007 to 2010. From 2000 to 2007, he served in Corporate Controller and Director of Finance roles for Trilogy Enterprises, Momentum Software and Alticast, Inc. He spent nine years with PricewaterhouseCoopers, as a Manager in the audit and assurance, transaction services and global capital markets practices. Mr. Schoen received his Bachelor of Science in Finance from Santa Clara University.
Positions
- Company NameFilana Therapeutics, Inc.Stock CodeFLNAPositionChief Financial OfficerColleagues
- RJRichard Jon BarryCEO, President & Director
- CNClaude NicaiseIndependent Chairman
- RCR. Christopher CookChief Operating & Legal Officer
- GTGeorge ThorntonSenior Vice President of Technology
- MZMichael ZamlootSenior Vice President of Technical Operations
- PGPierre GravierIndependent Director
- RERobert Eugene AndersonIndependent Director
- GLGrant L. SchoenhardMember of Scientific Advisory Board
